Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adamis Pharmaceuticals Corp    ADMP

ADAMIS PHARMACEUTICALS CORP (ADMP)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/10/2018 | 10:19pm CEST

Item 2.02 Results of Operations and Financial Conditions

On August 10, 2018, Adamis Pharmaceuticals Corporation (the "Company") issued a press release announcing certain financial information for the quarter ended June 30, 2018. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Form 8-K and the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits.


Exhibit No. Exhibit Description

99.1 Press release dated August 10, 2018

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ADAMIS PHARMACEUTICALS COR
09/28ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
09/27FDA OKs Lower Dose of EpiPen Alternative Drug That Adamis Licensed to Sandoz
DJ
09/27Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Produ..
GL
09/06ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
08/28ADAMIS PHARMACEUTICALS : Provides Business Update
AQ
08/27Adamis Pharmaceuticals Provides Business Update
GL
08/10ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition, Fin..
AQ
08/10ADAMIS : 2Q Earnings Snapshot
AQ
08/10Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Bu..
GL
08/09ADAMIS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
More news
News from SeekingAlpha
10/04ADAMIS AND NOVARTIS : Gunning For Mylan's EpiPen 
10/01ADAMIS PHARMACEUTICALS : Where Do We Go From Here? 
09/28Midday Gainers / Losers (09/28/2018) 
09/28Adamis investors "sell on the news" following FDA nod for low-dose Symjepi; s.. 
09/28PREMARKET LOSERS AS OF 9 : 05 am (9/28/2018) 
Financials ($)
Sales 2018 21,5 M
EBIT 2018 -28,5 M
Net income 2018 -28,6 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 6,27x
Capi. / Sales 2019 3,73x
Capitalization 135 M
Chart ADAMIS PHARMACEUTICALS CORP
Duration : Period :
Adamis Pharmaceuticals Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAMIS PHARMACEUTICALS COR
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 9,00 $
Spread / Average Target 216%
EPS Revisions
Managers
NameTitle
Dennis J. Carlo President, Chief Executive Officer & Director
Richard C. Williams Chairman
Karen K. Daniels Vice President-Operations
Robert O. Hopkins Chief Financial Officer, Secretary & VP-Finance
Thomas H. Moll Vice President-Research
Sector and Competitors
1st jan.Capitalization (M$)
ADAMIS PHARMACEUTICALS CORP-33.41%148
JOHNSON & JOHNSON-0.48%374 244
PFIZER22.86%257 933
NOVARTIS5.63%220 104
ROCHE HOLDING LTD.-0.63%206 610
MERCK AND COMPANY28.97%192 044